Our mission is to prevent, treat and cure lupus through medical research. 100% of all donations goes to support lupus research programs because the ALR board of directors funds all administrative and fundraising costs.
Features
Introducing the ALR's new Podcast Series!
Turning Promising Ideas into Treatments
Events
ALR One Love. One Cause. Gala Celebration
News
Human Genome Sciences and GlaxoSmithKline Announce FDA Priority Review Designation for BENLYSTA (belimumab) as a Potential Treatment for Systemic Lupus ErythematosusLupus Congress 2010 Special Report
Snoop Dogg Talks Of Daughter's Lupus
GlaxoSmithKline Says Partner HGSI Files Benlysta For US Approval
Bulletin on Lupus Drugs in Development
Additional Findings from the BENLYSTA™ (belimumab) BLISS-76 Phase III Clinical Trial Announced
The Alliance for Lupus Research is pleased to share our second annual American College of Rheumatology (ACR) Meeting Special Report
Grants
2010 Target Identification in Lupus Grant











